High Levels of Circulating Monocytic Myeloid-Derived Suppressive-Like Cells Are Associated With the Primary Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: An Exploratory Analysis

BackgroundImmunotherapy has become the standard of care for non-small cell lung cancer (NSCLC) patients. Some patients experience primary resistance to immunotherapy. Currently, we lack a marker of resistance to immunotherapy. Myeloid-derived suppressive-like cells (MDSCs) can reduce tumor response...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Giuseppe Bronte, Elisabetta Petracci, Serena De Matteis, Matteo Canale, Ilaria Zampiva, Ilaria Priano, Paola Cravero, Kalliopi Andrikou, Marco Angelo Burgio, Paola Ulivi, Angelo Delmonte, Lucio Crinò
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2022-04-01
Serija:Frontiers in Immunology
Teme:
myeloid-derived suppressive cells
primary resistance
immunotherapy
non-small cell lung cancer
immune checkpoint inhibitors
Online pristup:https://www.frontiersin.org/articles/10.3389/fimmu.2022.866561/full
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items